US OptionsDetailed Quotes

AXNX241115P80000

Watchlist

0.00
0.000.00%

15min DelayClose Oct 31 09:30 ET

0.00High0.00Low

Axonics Stock Discussion

Moomoo AI

Mar 1 13:55

Analysts' consensus shows Axonics performing as expected, with no major estimate changes post recent results. Despite a predicted slowdown in revenue growth, Axonics is still expected to outpace the wider industry.

Analysts Have Made A Financial Statement On Axonics, Inc.'s (NASDAQ:AXNX) Full-Year Report

Moomoo AI

Feb 12 08:44

Axonics' consistent revenue growth, despite last year's lack of profit, has led to a 33% annual increase in share price over the past five years, making it a potential investment opportunity.

Investing in Axonics (NASDAQ:AXNX) Five Years Ago Would Have Delivered You a 313% Gain

Moomoo AI

Jan 8 06:25

Meghan Scanlon from Boston Scientific forecasts merger to enhance support for urologists handling chronic conditions. Acquisition may improve earnings per share over time, though GAAP earnings may see lesser increase due to related expenses.

Press Release: Boston Scientific Announces Agreement to Acquire Axonics, Inc.

Moomoo AI

Jan 3 20:12

Investors believe in Axonics' potential for future revenue growth, supporting higher stock prices despite a high P/S ratio. They discount the chance of a revenue decrease, but risks and other factors must also be considered.

Axonics, Inc.'s (NASDAQ:AXNX) P/S Still Appears To Be Reasonable

Moomoo AI

Nov 7, 2023 05:18

Axonics' strong revenue growth may be driving its stock performance and could be attractive for growth investors. The recent sell-off may open up investment opportunities if long-term growth signs are positive.

Axonics (NASDAQ:AXNX) Delivers Shareholders Strong 29% CAGR Over 5 Years, Surging 8.0% in the Last Week Alone

Peter Koh

Aug 26, 2023 11:13

$Axonics (AXNX.US)$ Getting ready to take off

Columns Top upgrades and downgrades on 4/13

Upgrades
• $Booz Allen Hamilton Holding Corp (BAH.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $Humana (HUM.US)$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB Hunt Transport Services (JBHT.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB Hunt Transport Services (JBHT.US)$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI International (CACI.US)$: Goldman Sachs Downgrad...

Analysts Notebook

Apr 6, 2022 06:01

Columns Top upgrades and downgrades on 4/6

Upgrades
• $Banc of California (BANC.US)$: Raymond James Upgrades to Outperform from Market Perform - PT $22
• $Cullen/Frost Bankers (CFR.US)$: Raymond James Upgrades to Outperform from Market Perform
• $W.W. Grainger (GWW.US)$: Wolfe Research Upgrades to Outperform from Peerperform
• $Invitation Homes Inc (INVH.US)$: Evercore ISI Upgrades to Outperform from In Line - PT $46 (from $44)
• $PCB Bancorp (PCB.US)$: Raymond James Upgrades to Outperform from Market Perfor...

Moomoo Breakfast US

Mar 8, 2022 07:23

Columns Today's pre-market stock movers: MNDT, VYGR, DLTR and more

Gainers
- $Consolidated Communications (CNSL.US)$ +14.6%: Searchlight affirms 34.6% active holding; to evaluate the possibility of a further investment in or full acquisition.
- $Voyager Therapeutics (VYGR.US)$ +12.2%: agrees to licensing option with $Novartis AG (NVS.US)$; Voyager receives $54 million upfront.
- $Aegon Ltd (AEG.US)$ +6%: provides update on Russian and Belarusian investments following invasion of Ukraine.
- $AZZ Inc (AZZ.US)$ +...

No comment yet